These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7889806)

  • 1. Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
    Bronson ME; Barrios-Zambrano L; Jiang W; Clark CR; DeRuiter J; Newland MC
    Drug Alcohol Depend; 1994 Dec; 36(3):161-6. PubMed ID: 7889806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of designer drugs on the chicken embryo and 1-day-old chicken.
    Bronson ME; Jiang W; Clark CR; DeRuiter J
    Brain Res Bull; 1994; 34(2):143-50. PubMed ID: 7913870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1991 Mar; 38(3):539-44. PubMed ID: 1676847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
    Steele TD; McCann UD; Ricaurte GA
    Addiction; 1994 May; 89(5):539-51. PubMed ID: 7913850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conditioned taste aversions produced by MDMA and d-amphetamine.
    Lin HQ; Atrens DM; Christie MJ; Jackson DM; McGregor IS
    Pharmacol Biochem Behav; 1993 Sep; 46(1):153-6. PubMed ID: 7902981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative profile of MDMA.
    Schechter MD
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1533-7. PubMed ID: 2874566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.
    Evans SM; Johanson CE
    Drug Alcohol Depend; 1986 Oct; 18(2):159-64. PubMed ID: 2877843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    McKenna DJ; Peroutka SJ
    J Neurochem; 1990 Jan; 54(1):14-22. PubMed ID: 1967141
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA as a discriminative stimulus: isomeric comparisons.
    Schechter MD
    Pharmacol Biochem Behav; 1987 May; 27(1):41-4. PubMed ID: 2886996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
    St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
    Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K; Maeda H; Goromaru T
    Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalization of serotonin and dopamine ligands to the discriminative stimulus effects of different doses of ±3,4-methylenedioxymethamphetamine.
    Webster JI; Harper DN; Schenk S
    Behav Pharmacol; 2017 Jun; 28(4):245-254. PubMed ID: 27922542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.
    Berquist MD; Leth-Petersen S; Kristensen JL; Fantegrossi WE
    Drug Alcohol Depend; 2020 Mar; 208():107850. PubMed ID: 31954950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.